from WIRED1 year agoThe candidate that's farthest along is the single-dose ChAd3 Ebola Sudan vaccine, which is being developed by the Sabin Vaccine Institute, a nonprofit based in Washington, DC. Read at WIRED #epidemiology[add][|| ... ]